Your session is about to expire
← Back to Search
BRIGHT Coaching Program for Developmental Disabilities
N/A
Waitlist Available
Led By Annette Majnemer, PhD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children between the ages of 1.5 years to 4.5 years at enrolment
Be younger than 18 years old
Must not have
Non-English or non-French speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10-15 minutes at each study visit (at baseline, 8 months post-entry [immediately post-intervention], 12 months post-entry [follow-up])
Awards & highlights
No Placebo-Only Group
Summary
This trial will test whether a standardized coaching program can help families of children with developmental disabilities across multiple sites in different settings.
Who is the study for?
This trial is for families with children aged 1.5 to 4.5 years who are suspected of or confirmed to have developmental delays and are new to a service agency for assessment/intervention. Participants must be able to complete three assessments over a year and speak English or French.
What is being tested?
The study tests if a standardized coaching program, which includes a coach, online education tools, and peer support network, can improve parental health, family healthcare experience, and be cost-effective compared to usual care.
What are the potential side effects?
Since this trial involves non-medical interventions like coaching and online support rather than drugs or medical procedures, traditional side effects aren't expected; however participants may experience emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child is between 1.5 and 4.5 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not speak English or French.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10-15 minutes at each study visit (at baseline, 8 months post-entry [immediately post-intervention], 12 months post-entry [follow-up])
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10-15 minutes at each study visit (at baseline, 8 months post-entry [immediately post-intervention], 12 months post-entry [follow-up])
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Family Empowerment Scale (FES) - change is being assessed.
Parent Sense of Competency (PSOC) Scale - change is being assessed.
Secondary study objectives
36-Item Short Form Survey (SF-36) - change is being assessed.
Measure of Process of Care - 20 (MPOC - 20) - change is being assessed.
Parenting Stress Index - 36 (PSI-36) - change is being assessed.
+1 moreOther study objectives
Demographic form
Readiness to receive coaching
Vineland Adaptive Behavior Scales (Vineland)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Group 2- Partial and delayed coachingExperimental Treatment2 Interventions
Parents in this group will have delayed and partial access to coaching, at the end of the 18-month period. Parents in this group will have a one-time session with a developmental coach who can give them guidance about their child's development. Parents in this group will also then get access to online parent education and peer support tools, indefinitely, until the online platform is de-activated.
\* Both arms/groups\* will obtain usual care for their child, in addition and independent of full or partial coaching.
Group II: Group 1 - CoachingExperimental Treatment3 Interventions
Upon enrollment to the study, parents in this group will have immediate access to the full intervention:
* Coaching: Telephone contact with coaches, who will provide information, education and support about the child's development. Coaching will be adapted to family needs, situation, preferences and child's condition.
* Online parent education: Parents will be provided access to empowering online tools, such as educational resources, chosen or developed by other parents and researchers.
* Peer support tools: Parents will have access to a secure online social media tool to connect to other parents going through a similar experience. Through this tool, parents can help support each other, and share their experiences and knowledge.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Coaching
2016
Completed Phase 3
~5600
Online peer support
2018
N/A
~310
Online parent education
2018
N/A
~310
Find a Location
Who is running the clinical trial?
McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
470 Previous Clinical Trials
166,655 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,388 Previous Clinical Trials
26,517,767 Total Patients Enrolled
University of AlbertaOTHER
939 Previous Clinical Trials
433,607 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have difficulties or delays in one or more areas of development, such as movement, thinking, speaking, socializing, or behavior.My child is between 1.5 and 4.5 years old.I do not speak English or French.I am willing and able to participate in check-ups, whether by phone or in person.
Research Study Groups:
This trial has the following groups:- Group 1: Group 2- Partial and delayed coaching
- Group 2: Group 1 - Coaching
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger